Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04774757 | Systemic Therapy Sequenced Isolated PALND for mCRC | unknown | N/A | 39 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT04037319 | Atrial Fibrillation After Surgery for Colorectal Cancer(AFAR) | unknown | — | 720 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Oct 8, 2021 |
| clinicaltrials |
| NCT02826837 | LEAC-102 for Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 30 | Taiwan Leader Biotech Corp.INDUSTRY | 0 | Oct 6, 2021 | clinicaltrials |
| NCT05051592 | Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients | unknown | — | 40 | National University Hospital, SingaporeOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT01899547 | Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum(LASRE) | unknown | N/A | 1,070 | Fujian Medical UniversityOTHER | 1 | Oct 1, 2021 | clinicaltrials |
| NCT05028192 | Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia(MEx) | unknown | — | 144 | University of Turin, ItalyOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT04781270 | mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases | unknown | Phase 3 | 308 | Fudan UniversityOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT04069455 | ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma | unknown | N/A | 270 | Zhejiang UniversityOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT02948348 | Study to Nivolumab Following Preoperative Chemoradiotherapy | unknown | Phase 1 / Phase 2 | 90 | Takayuki YoshinoOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT05046756 | Postoperative Prognosis Management Service Based mHealth for Colon Cancer Patients | unknown | N/A | 324 | Korea University Anam HospitalOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT04434963 | Safety and Feasibility of Reversible Induction Strategy | unknown | — | 20 | RenJi HospitalOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT02406118 | Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TME | unknown | N/A | 49 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 10, 2021 | clinicaltrials |
| NCT02421432 | Evaluation of the Safety and the Efficacy of Transanal TME in Difficult Cases | unknown | N/A | 12 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 10, 2021 | clinicaltrials |
| NCT05039060 | Modified MAC Diet and Gut Microbiota in CRC Patients | unknown | N/A | 40 | Korea University Anam HospitalOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04287400 | Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer | unknown | — | 210 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 5, 2021 | clinicaltrials |
| NCT05035914 | Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 94 | Guangzhou University of Traditional Chinese MedicineOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT04890015 | The Impact of Transanal Decompression Tube Placement After Colorectal Anastomosis: A Randomized Trial(SONDES) | unknown | N/A | 202 | Institut d'Investigació Biomèdica de Girona Dr. Josep TruetaOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT04905147 | Efficacy of Mosapride on Recovery of Intestinal Motility After Elective Colorectal Cancer Surgery | unknown | N/A | 44 | Mahidol UniversityOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT03126071 | Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer | unknown | Phase 2 | 100 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT04241731 | A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer | unknown | Phase 2 | 50 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT04324476 | A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer | unknown | Phase 2 | 50 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT05026268 | The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis(LaRCIa) | unknown | N/A | 2 | State Scientific Centre of Coloproctology, Russian FederationOTHER_GOV | 1 | Aug 30, 2021 | clinicaltrials |
| NCT04948034 | The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE) | unknown | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT05020613 | Early and Late Removal of the Urinary Catheter After Rectum Resection | unknown | N/A | 120 | Marmara UniversityOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT04466254 | Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer | unknown | Phase 2 | 75 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.INDUSTRY | 1 | Aug 23, 2021 | clinicaltrials |
| NCT03727763 | Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT) | unknown | Phase 2 | 30 | Shanghai Changzheng HospitalOTHER | 1 | Aug 19, 2021 | clinicaltrials |
| NCT04906733 | Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients. | unknown | — | 80 | D1 Medical Technology (Shanghai) Co., Ltd, ChinaINDUSTRY | 1 | Aug 13, 2021 | clinicaltrials |
| NCT04999072 | Carbohydrate Antigen 19-9 in Colorectal Cancer | unknown | — | 4,972 | Seoul National University HospitalOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04989855 | Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score | unknown | Phase 2 | 48 | Sun Yat-sen UniversityOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT04988191 | Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer | unknown | Phase 1 / Phase 2 | 44 | Peking UniversityOTHER | 1 | Aug 3, 2021 | clinicaltrials |
| NCT04980950 | "The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients" | unknown | N/A | 80 | Medical University of GdanskOTHER | 0 | Jul 30, 2021 | clinicaltrials |
| NCT04970498 | Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer | unknown | — | 120 | Peking University Third HospitalOTHER | 1 | Jul 21, 2021 | clinicaltrials |
| NCT04969029 | Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 Mutations | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT02533271 | Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer(STELLAR) | unknown | Phase 3 | 600 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT03958435 | Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery | unknown | — | 20,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 15, 2021 | clinicaltrials |
| NCT04131803 | Probiotics Combined With Standard Chemotherapy Plus Targeted Therapy in Patients With Metastatic Colorectal Cancer | unknown | N/A | 140 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Jul 15, 2021 | clinicaltrials |
| NCT04380012 | A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer | unknown | Phase 2 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 15, 2021 | clinicaltrials |
| NCT02546596 | The Effect of Electro-Hyperthermia in Preoperative Radiotherapy for Locally Advanced Rectal Cancer | unknown | N/A | 76 | Yonsei Hyperthermia Study GroupOTHER | 1 | Jul 13, 2021 | clinicaltrials |
| NCT04947930 | Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population | unknown | — | 600 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04293419 | Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer(DUREC) | unknown | Phase 2 | 58 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Jun 21, 2021 | clinicaltrials |
| NCT04929652 | Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 48 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Jun 18, 2021 | clinicaltrials |
| NCT04687384 | Systemic and Peritoneal Inflammatory Response In Robotic-assisted And Laparoscopic Surgery for Colon Cancer | unknown | N/A | 50 | University of Southern DenmarkOTHER | 1 | Jun 16, 2021 | clinicaltrials |
| NCT04924686 | Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases | unknown | — | 600 | Zhujiang HospitalOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT04664504 | A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk | unknown | Phase 2 | 150 | Jing Jin, M.D.UNKNOWN | 1 | Jun 8, 2021 | clinicaltrials |
| NCT04917263 | IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.(IMMUNOREACT2) | unknown | — | 544 | University of PadovaOTHER | 1 | Jun 8, 2021 | clinicaltrials |
| NCT04917276 | Treatment Response Prediction System of mCRC Patients Based on CTC | unknown | — | 100 | Fudan UniversityOTHER | 0 | Jun 8, 2021 | clinicaltrials |
| NCT04917289 | CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients | unknown | Phase 3 | 100 | Fudan UniversityOTHER | 0 | Jun 8, 2021 | clinicaltrials |
| NCT04913233 | Establishment and Clinical Validation of New Technologies for Accurate Screening of Colorectal Cancer Based on Multi-omics | unknown | — | 9,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT04912258 | Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis | unknown | Phase 3 | 80 | Fudan UniversityOTHER | 1 | Jun 3, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Oct 11, 2021source: clinicaltrials